An overview on the seven pathogenic human coronaviruses.

Area of Science:

• Virology
• Infectious Diseases
• Public Health

Background:

• Seven human coronaviruses (HCoVs) are known, including common cold viruses (HCoV-NL63, -229E, -HKU1, -OC43) and more severe pathogens (SARS-CoV, MERS-CoV, SARS-CoV-2).
• Recent emergence of novel HCoVs (SARS-CoV, MERS-CoV, SARS-CoV-2) since 2000 highlights their pandemic potential and significant mortality rates.
• HCoVs pose risks, especially to the elderly and immunocompromised, with potential for future emergence due to zoonotic origins and viral replication patterns.

Purpose of the Study:

• To review and compare the distinct characteristics of the seven identified human coronaviruses.
• To elucidate the differences in accessory proteins, incubation periods, and pathogenicity among HCoVs.
• To provide a comprehensive overview of HCoV diversity and implications for public health.

Main Methods:

• Literature review of scientific publications on human coronaviruses.
• Comparative analysis of viral characteristics based on existing data.
• Synthesis of information regarding viral replication, pathogenicity, and clinical manifestations.

Main Results:

• Four common HCoVs typically cause mild, seasonal respiratory illness.
• Emerging HCoVs like SARS-CoV, MERS-CoV, and SARS-CoV-2 exhibit higher mortality and pandemic potential.
• All HCoVs share similarities in replication but differ significantly in accessory proteins, incubation times, and disease severity.

Conclusions:

• Understanding HCoV diversity is crucial for predicting and managing future outbreaks.
• Differences in viral components and replication influence pathogenicity and clinical outcomes.
• Ongoing surveillance and research are essential to address the threat of emerging coronaviruses.